Vetigenics creates novel immunotherapies to treat cancer and chronic disease in dogs without debilitating side effects. Our fully canine phage display libraries, enable rapid isolation of unique scFvs or CANIBODIES™ to any antigen based binding affinity, functionality and developability. CANIBODIES™ are entirely generated from naïve, canine immunoglobulin genes, requiring no caninization or affinity maturation, ready for formulating into mAbs, BiTEs, or CAR-T. CANIBODIES™ are designed for precision, efficacy and lack of immunogenicity, not possible with any other discovery approaches.